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The National Breast and Cervical Cancer Early Detection Pro-
gram (BCCP) in Ohio provides screening and treatment services
for uninsured low-income women aged 40 to 64. Because particip-
ation in the BCCP might engender greater self-efficacy for cancer
screening, we hypothesized that breast cancer and survival out-
comes would be better in BCCP participants who become age-eli-
gible  to  transition  to  Medicare  than  in  their  low-income non-
BCCP counterparts.
Methods
Linking data from the 2000 through 2009 Ohio Cancer Incidence
Surveillance  System with  the  BCCP database,  Medicare  files,
Ohio death certificates (through 2010), and the US Census, we
identified Medicare beneficiaries who were aged 66 to 74 and dia-
gnosed with incident invasive breast cancer. We compared the fol-
lowing outcomes between BCCP women (n = 93) and low-in-
come non-BCCP women (n = 420): receipt of screening mammo-
graphy in  previous  year,  advanced-stage  disease  at  diagnosis,
timely and standard care, all-cause survival, and cancer survival.
We conducted multivariable logistic regression and survival ana-
lysis to examine the association between BCCP status and each of
the outcomes, adjusting for patient covariates.
Results
Women who participated in the BCCP were nearly twice as likely
as low-income non-BCCP women to have undergone screening
mammography in the previous year (adjusted odds ratio,  1.77;
95% confidence interval, 1.01–3.09). No significant differences
were detected in any other outcomes.
Conclusion
With the exception of screening mammography, the differences in
outcomes were not significant, possibly because of the small size
of the study population. Future analysis should be directed toward
identifying the factors that explain these findings.
Introduction
Breast cancer is the most common cancer in women, claiming
more than 40,000 lives in 2011 alone (1). Of the 232,340 women
diagnosed with incident invasive breast cancer in 2013, 42% were
aged 65 or older (2).
Although breast  cancer is  amenable to screening,  one-third of
breast cancer diagnoses are for regional-stage or distant-stage dis-
ease (2), and these patients have a poor prognosis. Numerous initi-
atives have been developed to increase screening rates by improv-
ing outreach and reducing barriers to mammography. One such
initiative is the National Breast and Cervical Cancer Early Detec-
tion Program (BCCP) of the Centers for Disease Control and Pre-
vention, implemented in 1990 (3). Targeting low-income unin-
sured women, the BCCP in Ohio provides clinical breast examina-
tions and diagnostic mammography to women aged 40 to 64 and
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screening mammography to women aged 50 to 64. Outreach ef-
forts have focused not only on one-time mammography use but
also on repeat use.
Evaluations of the BCCP have focused mostly on outcomes in wo-
men younger than 64 (4–7). However, the benefits of having parti-
cipated in the BCCP may extend well beyond the years in which a
woman is eligible for BCCP services as she becomes age-eligible
for and transitions to Medicare. First, past screening behavior (8)
is strongly associated with use of subsequent mammography, pos-
sibly because of habit and reassurance (9). Second, participation in
the  BCCP might  impart  greater  knowledge  of  the  benefits  of
breast cancer screening (10). Third, and just as important, particip-
ating in the BCCP might provide women the opportunity to con-
nect and develop a continuity of care relationship with primary
care providers. This factor is strongly and positively associated
with screening mammography (11,12) and reduced breast cancer
mortality (13), especially given the role of primary care providers
in preventing treatment delays (14). Additional factors contribut-
ing to better survival in women with screening-detected breast
cancer are breast cancer diagnosis at earlier stages of the disease
and the fact  that  screening-detected tumors tend to be slower-
growing than those detected otherwise (15). This survival advant-
age in screening-detected breast cancer patients over other breast
cancer patients persists even after adjusting for tumor characterist-
ics (15,16).
The objective of this study was to compare screening and cancer-
related outcomes between 2 groups of  Medicare beneficiaries:
former BCCP participants and their low-income non-BCCP coun-
terparts. We hypothesized that among Medicare beneficiaries with
breast cancer, former BCCP participants would be more likely
than their low-income non-BCCP counterparts to be diagnosed
with cancer after screening, rather than after diagnostic (or no)
mammogram, and more likely to have better treatment and surviv-
al outcomes.
Methods
We used linked records from the Ohio Cancer Incidence Surveil-
lance System (OCISS), the state’s BCCP data, Medicare enroll-
ment and claims files, the US Census, and death certificate files.
This study was approved by the Case Western Reserve University
institutional review board (IRB); by the IRB of the Ohio Depart-
ment of Health, which maintains the OCISS, BCCP, and death
certificate files; and by the Centers for Medicare and Medicaid
Services (CMS).
Data sources and linkage
Ohio Cancer Incidence Surveillance System
Established in 1991, the OCISS captures data on incident cases of
cancer diagnosed among Ohio residents. With the exception of
carcinoma in situ of the cervix and nonmelanoma skin cancers, all
other cancers are required by law to be reported to the OCISS. Ac-
cording to a report by the OCISS, its completeness for female
breast cancer was on average 88% during the study period (per-
sonal communication, Holly Sobotka, MS, Ohio Department of
Health, March 2015).
In addition to patient identifiers, the OCISS record has the follow-
ing information: patient residence address (used for geocoding);
patient demographics (age at time of diagnosis and race); date of
diagnosis; anatomic cancer site; and the Surveillance, Epidemi-
ology, and End Results (SEER) summary stage. Although the vari-
ables on tumor size, number of lymph nodes, and metastatic status
are available through the OCISS, these variables have large pro-
portions of missing values. Thus, we used the SEER summary
stage rather than a more detailed stage classification.
In this study, the OCISS was used to identify women diagnosed
with incident breast cancer from January 1, 2000, through June 30,
2009,  and to  retrieve the geocoded address  of  the patient,  her
demographics, date of cancer diagnosis, and tumor stage.
BCCP database
This database includes records for women served by Ohio’s BCCP
since its inception in 1994. It comprises 3 files: the first file in-
cludes 1 record for each participant and has identifiers,  which
were used to link with data from the OCISS; the second file in-
cludes a record for each encounter; and the third file itemizes the
procedures received at each encounter. From this database, we
identified 1-time BCCP participants and repeat BCCP participants.
Medicare enrollment and claims files
The Master Beneficiary Summary File (MBSF) includes 1 record
for each individual enrolled in Medicare in a given calendar year.
In  addition  to  patient  demographics,  the  MBSF  record  has
monthly variables to indicate beneficiaries’ participation in Part A,
Part  B,  and  managed  care  programs  as  well  as  dual
Medicare–Medicaid enrollment status.
The Medicare Provider, Analysis, and Review (MedPAR) file in-
cludes records for hospital admissions. Each record indicates the
date of service and International Classification of Diseases, 9th
Revision, Clinical Modification (ICD-9-CM) diagnosis and pro-
cedure codes.  The Outpatient  and Carrier  Standard Analytical
Files (SAFs) include claims for services received in outpatient in-
stitutional and noninstitutional settings. Records from these files
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also indicate dates of services and ICD-9-CM diagnosis codes.
The procedure codes are documented in Current Procedural Ter-
minology, 4th Edition (CPT-4), or in the Healthcare Common Pro-
cedure Coding System.
These files, which were available to us for 2000 through 2009,
were used to further define our study population and to identify
comorbid conditions, nursing home status, and timing and receipt
of cancer treatment.
US Census data
Using the geocoded addresses from the OCISS, we obtained data
on income and educational attainment for the census tract and
census block group levels. Census tracts were also used to determ-
ine whether a woman’s area of residence was in a Medically Un-
derserved Area (MUA) or was part of a Medically Underserved
Population (MUP), according to areas listed by the Health Re-
sources and Service Administration and the Ohio Department of
Health. The listings were obtained in March 2012.
Ohio death certificate data
The Ohio death certificate file includes a death certificate record
for every deceased resident of Ohio. In addition to identifiers, the
death certificate indicates the date and underlying cause of death.
This file was used to analyze all-cause survival and cancer surviv-
al.
First we linked records from the OCISS with records in BCCP
files, using patient identifiers (patient first and last name, social se-
curity number, and date of birth) and relying on a multistep de-
terministic matching algorithm, consistent with previous studies
(17–19).  Next,  identifiers  were  sent  to  CMS for  linkage  with
Medicare files.
Study population
The study population included women with low incomes, residing
in  Ohio,  aged 66 to  74,  and diagnosed with  incident  invasive
breast cancer during the study period (n = 14,769). Although the
age of enrollment in Medicare is 65 years, we used 66 years as the
lower age limit to allow for a 1-year look-back period to identify
comorbidities and receipt of screening mammography. We set the
upper age limit at 74 because the US Preventive Services Task
Force does not recommend screening mammography beyond that
age (20).
From this group, we selected 1) those who had participated in the
BCCP program before becoming age-eligible for Medicare, and 2)
low-income Medicare beneficiaries. To overcome the absence of
income  data  for  Medicare  beneficiaries,  we  used  the  median
household income at the census block group level (MHI-CB) as a
proxy for individual income. Medicare beneficiaries were identi-
fied as low-income if the MHI-CB was below the 10th percentile,
based on the distribution of this measure for women with breast
cancer statewide during the study period.
To minimize the chances of having incomplete claims data, we
limited our study population to those who were enrolled in Part A
and Part B and received their care through the traditional fee-for-
service system in the 12 months before and 6 months after cancer
diagnosis. We also excluded women with unstaged or unknown-
stage cancer. Our final study population included 513 women.
Variables of interest
Our outcome variables were receipt of screening mammography in
the previous year, advanced-stage cancer, time to treatment, re-
ceipt  of  standard treatment,  and all-cause and cancer survival.
Screening mammography was identified in claims indicating a
CPT code  of  76092,  with  no  evidence  in  any  of  the  patient’s
claims files of a previous diagnosis of breast cancer (ICD-9 codes
174.xx or 233.0) or breast mass (ICD-9 code 611.72) in the previ-
ous year, or a mammogram (CPT codes 76090–76092) in the pre-
vious 11 months (21). Advanced-stage cancer was defined as re-
gional-stage or distant-stage cancer at diagnosis, excluding cases
that were unstaged or unknown-stage cancer. Time to treatment
was defined as the time elapsed between date of diagnosis and re-
ceipt of the first cancer-directed treatment. Receipt of standard
treatment was defined for local-stage disease as 1) mastectomy or
2) lumpectomy plus radiation therapy, and for regional-stage dis-
ease as the same treatment as for local-stage disease plus chemo-
therapy. All-cause survival and cancer survival were based on the
time elapsed between date of cancer diagnosis and date of death
and the underlying cause of death.
Our  main  independent  variable  was  BCCP status  (yes  or  no),
defined as yes if a woman was identified in the OCISS, BCCP,
and Medicare files. In addition, we created a variable to indicate
whether a woman had participated in BCCP only once (defined as
one-time participant) or multiple times (defined as repeat parti-
cipant). Because of the small sample sizes of the one-time and re-
peat participants, we conducted the multivariable analyses after
combining the 2 groups.
We grouped women according to selected demographic character-
istics. We established 2 categories of age (66–69 y, 70–74 y) and 2
categories of race (African American and other); we combined the
category for white with the categories for all other races/ethnicit-
ies because of the small number of cases who were not white or
African American. We established 3 categories of marital status
(married, not married, and unknown). Low educational attainment
was defined as residing in a census block group in which the per-
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centage of adults with a high school diploma was in the lowest
10th percentile, based on the distribution of this measure for wo-
men with breast cancer statewide. For place of residence, we cre-
ated indicators of whether women resided in Appalachian/rural,
metropolitan, or suburban counties and whether they resided in a
census tract or county identified as an MUA or MUP. In some
counties,  an  MUA was  based  on  a  service  area,  rather  than  a
census tract; accordingly, we coded a county as MUA or MUP for
all or an unknown part of the county. Thus, counties were categor-
ized as none, part, or all/unknown MUA/MUP. Finally, to charac-
terize the chronic disease burden and complexity of care for our
study population, we created variables for 1) number of comorbid-
ities (0, 1, or ≥2) identified in claims data for services received in
the year before cancer diagnosis, using Elixhauser’s listing of con-
ditions (22); 2) dual Medicare–Medicaid enrollment (yes or no), as
identified from the monthly indicators in the Medicare enrollment
file for the 12-month period before cancer diagnosis; and 3) resid-
ence in a nursing home (yes or no) in the 6 months before or after
cancer diagnosis, using a validated claims-based algorithm (23).
Analysis
In addition to descriptive analysis, we used multivariable regres-
sion analysis to evaluate the association between BCCP status and
each of the outcomes, after adjusting for patient covariates. For di-
chotomous variables, we developed logistic regression models; for
time-to-event  models,  we  developed  Cox proportional  hazard
models. We conducted 2 additional analyses: propensity score to
adjust for potential selection bias and sensitivity analysis by in-
come level.
The propensity scores, based on age, race, marital status, educa-
tional attainment, dual Medicare–Medicaid eligibility status, area
of residence, residence in a MUA or MUP, number of comorbidit-
ies, and residence in nursing home, were included in the regres-
sion models in quintiles. For the cancer survival model, we com-
bined the 4th and 5th quintiles to remedy for small numbers.
According to the BCCP, low income is defined as an income be-
low 200% of the federal poverty level — a measure based on the
number of people in a household. As noted earlier, however, we
identified low-income women as those residing in block groups
with MHI-CB in the lowest 10th percentile (24). We therefore
conducted a sensitivity analysis by comparing outcomes among
BCCP women with those of non-BCCP women at each of 2 in-
come levels: MHI-CB in the lowest 5th percentile and MHI-CB in
the lowest 15th percentile.
Results
Our study population had 93 BCCP and 420 low-income non-
BCCP women. Of the BCCP women, 57 (61%) were repeat parti-
cipants. The BCCP group and non-BCCP group differed signific-
antly in their sociodemographic distribution and place of resid-
ence (Table 1). The percentage of women aged 70 to 74 was signi-
ficantly higher among non-BCCP women than among BCCP wo-
men (58.1% vs 30.1%). In addition, we found a lower percentage
of  African  American  women  in  the  BCCP  group  (19.4%  vs
39.8%); a lower percentage of women residing in areas of low
educational attainment (small numbers and percentages masked in
accordance with Centers for Medicare and Medicaid Services’ pri-
vacy rules); a lower percentage residing in MUA or MUP regions
(66.7% vs 88.6%); and a lower percentage of women with 1 or
more comorbid conditions (66.7% vs. 75.7%).
The percentage of women undergoing screening mammography in
the year before cancer diagnosis was 51.6% in the BCCP group
and  38.8%  in  the  low-income  non-BCCP  group  (P  =  .02).
However, the proportion of women diagnosed with regional-stage
or distant-stage disease was similar in the 2 groups (31.2% vs
32.1%), and it was lowest among repeat BCCP users (24.6%). Re-
ceipt of standard treatment was lower in the BCCP group than in
the low-income non-BCCP group (72.7% vs 78.4%) and lowest
among one-time BCCP users (61.8%). None of these differences
were significant. Similarly, neither all-cause survival (log-rank χ2
= 1.2; P = .27) nor cancer survival (log-rank χ2 = 1.7; P = .19)
differed significantly between the 2 groups.
Adjusting for potential  confounders and propensity scores,  we
found that the BCCP group was significantly more likely than the
low-income non-BCCP group to  have had screening mammo-
graphy (adjusted odds ratio [AOR], 1.77; 95% confidence interval
[CI], 1.01–3.09) (Table 2). No significant differences were detec-
ted in any other outcomes (Table 2 and Table 3).
The sensitivity analysis by income level yielded 1 noteworthy dif-
ference: when we compared outcomes between BCCP women and
non-BCCP women residing in census block groups with MHI-CB
in the lowest 5th percentile, we found no significant difference in
the likelihood to have had screening mammography (AOR, 1.23;
95% CI, 0.63–2.40); however, this may have been due to a small
sample  size.  In  contrast,  when  comparing  outcomes  between
BCCP women and non-BCCP women residing in census block
groups with incomes in the lowest 15th percentile, BCCP women
were nearly twice as likely to have undergone screening mammo-
graphy (AOR, 1.90; 95% CI, 1.16–3.12).
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Discussion
This study compared breast cancer outcomes between Medicare
beneficiaries with a history of participation in the BCCP and their
low-income non-BCCP counterparts. The findings indicated that
compared with low-income non-BCCP Medicare beneficiaries,
former BCCP women were significantly more likely to have un-
dergone screening mammography before cancer diagnosis. The
results pertaining to breast cancer outcomes were mixed, although
none of the differences were significant.
To our knowledge, this is the first study to document the lasting
effects of participation in the BCCP among women who become
age-eligible and transitioned to Medicare. The differentials in the
outcomes of interest, or lack thereof, provide a glimpse of what we
might observe after the implementation of the Affordable Care Act
(ACA), when many uninsured women receive insurance coverage.
Nonetheless, to a great extent, these findings, especially the great-
er likelihood of former BCCP participants to undergo screening
mammography, reflect important differences in health care–seek-
ing behaviors between former BCCP participants and their low-in-
come  non-BCCP  counterparts.  However,  reasons  why  better
screening did not translate into early-stage diagnosis and receipt of
standard treatment remain to be explored.
Our study has several limitations. First, the lack of significant dif-
ferences probably resulted from a small sample size, especially for
BCCP participants, despite pooling nearly 10 years of data. In a
follow-up study, it would be interesting to expand the study popu-
lation by including data from multiple states. Second, low-income
women in our comparison group were identified on the basis of
MHI-CB rather than at the individual level; however, such meas-
ures have been deemed adequate to evaluate socioeconomic in-
equalities (25). Furthermore, our criterion for defining low-in-
come women (those residing in census block groups with an MHI-
CB in the lowest  10th percentile)  was somewhat arbitrary,  al-
though consistent with a previous study (24). To address this limit-
ation, we conducted sensitivity analyses by identifying comparis-
on groups at 2 income thresholds — one with MHI-CB at the low-
est 5th percentile and the other with MHI-CB at the lowest 15th
percentile — and we found some differences in screening mam-
mography. We also noted some differences in cancer stage at dia-
gnosis, although these differences were not significant. Third, be-
cause this study was not randomized, there may have been selec-
tion bias due to inherent differences between former BCCP wo-
men and non-BCCP women. We addressed this limitation with the
propensity score approach in our analysis.
Despite these weaknesses, our study informs the discussion on the
contribution of the BCCP to the improvement of breast cancer out-
comes in low-income women, especially in the context of Medi-
caid expansion and the implementation of the ACA. While the
new policies will likely improve access to care, it will be import-
ant to determine whether, through an organized rather than an op-
portunistic approach to screening (26,27), the BCCP may offer a
venue to improve breast and cervical cancer screening above and
beyond the improvements that might be achieved with the imple-
mentation of Medicaid expansion and the ACA alone, especially
given low reimbursement rates and providers’ reluctance to serve
Medicaid patients. Indeed, while an organized approach to screen-
ing relies on policy and an adequate call-recall system, the oppor-
tunistic approach will depend on individual-related and provider-
related factors, such as knowledge and behavior. Future studies
weighing the benefits of Medicaid expansion and the ACA versus
the benefits of the BCCP need to account for these factors.
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Tables
Table 1. Distribution of the Study Population Among BCCP Women and Low-Incomea Non-BCCP Women, Ohio,
2000–2009b
Characteristic
BCCP One-Time Users (N
= 36)c
BCCP Repeat Users (N
= 57)c





66–69 66.7 71.9 69.9e 41.9
70–74 33.3 28.1 30.1 58.1
Race
African American  —  — 19.4e 39.8
Other  —  — 80.6 60.2
Marital status
Married  —  —  — 23.6
Not married 69.4 64.9 66.7 70.5
Unknown  —  —  — 6.0
Educational attainmentf
Low  —  —  —e 46.7
High  —  —  — 53.3
Dual Medicare–Medicaid eligibility
No 50.0 40.4 44.1 49.5
Yes 50.0 59.6 55.9 50.5
County of residence
Appalachian or rural 41.7 43.9 43.0e 21.2
Metropolitan  —  — 40.9 72.4
Suburban  —  — 16.1 6.4
Residence in medically underserved area or population
None  —  —  —e 3.3
Part 72.2 63.2 66.7 88.6
All/unknown  —  —  — 8.1
Abbreviations: — , small cells (n < 11) were masked in accordance with the privacy rules of the Centers for Medicare and Medicaid Services, and an ad-
ditional cell in the same column was also masked to prevent the reader from deriving the numbers; BCCP, National Breast and Cervical Cancer Early
Detection Program; CI, confidence interval; SD, standard deviation.
a Medicare beneficiaries were identified as low income if the median household income in the residence census block group was below the 10th per-
centile, based on the distribution of median household incomes across the state for breast cancer patients during the study period.
b Values are expressed as percentage of total unless otherwise indicated.
c BCCP one-time users and BCCP repeat users were compared; no significant differences were found (P < .05).
d Superscripts in this column refer to the comparison of measures between all BCCP women and low-income non-BCCP women; all other comparisons,
P < .05.
e P < .001.
f Low educational attainment defined as residing in a census block group in which the percentage of adults with a high school diploma was in the low-
est 10th percentile, based on the distribution of adults with high school diplomas across the state for breast cancer patients during the study period.
g P = .02.
h Analysis of treatment limited to women diagnosed with local-stage or regional-stage cancer.
(continued on next page)
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(continued)
Table 1. Distribution of the Study Population Among BCCP Women and Low-Incomea Non-BCCP Women, Ohio,
2000–2009b
Characteristic
BCCP One-Time Users (N
= 36)c
BCCP Repeat Users (N
= 57)c





0  — 38.6 33.3g 24.3
1  — 29.8 30.1 22.6
≥2 44.4 31.6 36.6 53.1
Cancer stage at diagnosis
Local 58.3 75.4 68.8 67.9
Regional or distant 41.7 24.6 31.2 32.1
Lives in nursing home
No  —  — 88.2 80.2
Yes  —  — 11.8 19.8
Had screening mammography in year before cancer diagnosis
No 52.8 45.6 48.4g 61.2
Yes 47.2 54.4 51.6g 38.8
Time to treatment initiation, days
Median (95% CI) 49 (23–117) 35 (22–50) 41 (28–53) 34 (30–40)
Mean (SD) 61.4 (7.9) 50.8 (6.1) 56.8 (5.2) 62.8 (3.3)
Receipt of standard treatmenth
No 38.2 20.4 27.3 21.6
Yes 61.8 79.6 72.7 78.4
Abbreviations: — , small cells (n < 11) were masked in accordance with the privacy rules of the Centers for Medicare and Medicaid Services, and an ad-
ditional cell in the same column was also masked to prevent the reader from deriving the numbers; BCCP, National Breast and Cervical Cancer Early
Detection Program; CI, confidence interval; SD, standard deviation.
a Medicare beneficiaries were identified as low income if the median household income in the residence census block group was below the 10th per-
centile, based on the distribution of median household incomes across the state for breast cancer patients during the study period.
b Values are expressed as percentage of total unless otherwise indicated.
c BCCP one-time users and BCCP repeat users were compared; no significant differences were found (P < .05).
d Superscripts in this column refer to the comparison of measures between all BCCP women and low-income non-BCCP women; all other comparisons,
P < .05.
e P < .001.
f Low educational attainment defined as residing in a census block group in which the percentage of adults with a high school diploma was in the low-
est 10th percentile, based on the distribution of adults with high school diplomas across the state for breast cancer patients during the study period.
g P = .02.
h Analysis of treatment limited to women diagnosed with local-stage or regional-stage cancer.
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Table 2. Results From the Multivariable Analysis for Screening Mammography, Cancer Stage at Diagnosis, Time to Treat-










Breast and Cervical Cancer Early Detection Program
Yes 1.77 (1.01–3.09)b 1.04 (0.57–1.87) 0.90 (0.67–1.23) 0.69 (0.36–1.33)
No 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
Age, y
66–69 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
70–74 1.10 (0.67–1.81) 1.01 (0.61–1.69) 0.94 (0.72–1.23) 0.66 (0.35–1.24)
Race
African American 1.00 (0.64–1.56) 1.13 (0.71–1.78) 0.78 (0.61–0.99)c 0.87 (0.50–1.51)
Other 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
Marital status
Married 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
Not married 1.20 (0.75–1.92) 1.00 (0.61–1.63) 0.82 (0.64–1.05) 1.13 (0.65–1.97)
Unknown 0.63 (0.25–1.54) 0.51 (0.20–1.34) 0.69 (0.43–1.10) 1.35 (0.43–4.25)
Educational attainmentd
Low 0.53 (0.30–0.93)e 1.04 (0.57–1.89) 1.03 (0.76–1.40) 0.77 (0.39–1.53)
High 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
Dual Medicare–Medicaid eligibility
No 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
Yes 0.87 (0.56–1.36) 1.45 (0.91–2.31) 0.91 (0.72–1.16) 1.36 (0.79–2.35)
County of residence
Appalachian or rural 2.55 (1.33–4.87)f 0.94 (0.47–1.89) 0.98 (0.68–1.41) 0.90 (0.42–1.92)
Metropolitan 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
Suburban 2.01 (0.91–4.46) 1.43 (0.63–3.26) 1.18 (0.78–1.78) 0.65 (0.27–1.61)
a Except for the outcome of time to treatment initiation, all values are adjusted odds ratio (95% confidence interval). Values for the outcome of time to
treatment initiation are adjusted hazard ratio (95% confidence interval). Values for propensity scores (in quintiles) were not shown because they have
no bearing on the interpretation of the findings. P values are for analysis of maximum likelihood estimates; unless otherwise indicated, odds ratios and
hazard ratios are not significant at P < .05.
b P = .045.
c P = .04.
d Low educational attainment defined as residing in a census block group in which the percentage of adults with a high school diploma was in the low-
est 10th percentile, based on the distribution of this measure for women with breast cancer statewide.
e P < .001.
f P = .005.
g P = .03.
h P = .004.
i P = .01.
j P = .02.
k P = .002.
l P = .006.
m Analysis limited to patients diagnosed with local-stage or regional-stage cancer.
(continued on next page)
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(continued)
Table 2. Results From the Multivariable Analysis for Screening Mammography, Cancer Stage at Diagnosis, Time to Treat-










Residence in medically underserved area or population
None 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
Part 0.83 (0.28–2.47) 1.43 (0.42–4.89) 0.88 (0.50–1.55) 0.53 (0.13–2.12)
All/unknown 0.37 (0.10–1.32) 2.06 (0.50–8.47) 0.81 (0.42–1.56) 0.67 (0.14–3.36)
No. of comorbidities
0 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
1 0.89 (0.52–1.51) 0.83 (0.48–1.44) 1.11 (0.84–1.47) 0.54 (0.28–1.05)
≥2 0.64 (0.38–1.09) 0.55 (0.32–0.95)g 0.81 (0.61–1.08) 0.52 (0.27–1.03)
Cancer stage at diagnosis
Local 1 [Reference] — 1 [Reference] 1 [Reference]
Regional 0.52 (0.33–0.81)h — 1.08 (0.85–1.38) 0.25 (0.15–0.42)e
Distant 0.43 (0.15–1.25) — — —
Lives in nursing home
No 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
Yes 0.47 (0.26–0.83)i 1.90 (1.13–3.22)j 1.08 (0.80–1.46) 1.04 (0.51–2.11)
Had screening mammography in year before cancer diagnosis
No — 1 [Reference] 1 [Reference] 1 [Reference]
Yes — 0.51 (0.34–0.79)k 0.92 (0.74–1.15) 0.50 (0.31–0.82)l
Receipt of standard treatmentm
No — — 1 [Reference] —
Yes — — 2.50 (1.90–3.29)e —
a Except for the outcome of time to treatment initiation, all values are adjusted odds ratio (95% confidence interval). Values for the outcome of time to
treatment initiation are adjusted hazard ratio (95% confidence interval). Values for propensity scores (in quintiles) were not shown because they have
no bearing on the interpretation of the findings. P values are for analysis of maximum likelihood estimates; unless otherwise indicated, odds ratios and
hazard ratios are not significant at P < .05.
b P = .045.
c P = .04.
d Low educational attainment defined as residing in a census block group in which the percentage of adults with a high school diploma was in the low-
est 10th percentile, based on the distribution of this measure for women with breast cancer statewide.
e P < .001.
f P = .005.
g P = .03.
h P = .004.
i P = .01.
j P = .02.
k P = .002.
l P = .006.
m Analysis limited to patients diagnosed with local-stage or regional-stage cancer.
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Table 3. Results From the Multivariable Survival Analysis, Adjusted for Propensity Scoresa, Ohio, 2000–2009
Characteristic All-Cause Survival Cancer Survivalb
Breast and Cervical Cancer Early Detection Program
Yes 1.11 (0.59–2.06) 1.13 (0.38–3.33)
No 1 [Reference] 1 [Reference]
Age, y
66–69 1 [Reference]  —
70–74 0.92 (0.59–1.43)  —
Race
African American 0.99 (0.66–1.47)  —
Other 1 [Reference]  —
Marital status
Married 1 [Reference]  —
Not married 1.34 (0.82–2.20)  —
Unknown 0.96 (0.41–2.24)  —
Educational attainmentc
Low 0.90 (0.56–1.45)  —
High 1 [Reference]  —
Dual Medicare–Medicaid eligibility
No 1 [Reference]  —
Yes 1.33 (0.89–1.99)  —
County of residence
Appalachian or rural 0.69 (0.34–1.39)  —
Metropolitan 1 [Reference]  —
Suburban 0.99 (0.46–2.14)  —
Residence in medically underserved area or population
None 1 [Reference]  —
Part 0.29 (0.10–0.82)d  —
All/unknown 0.34 (0.10–1.17)  —
No. of comorbidities
0 1.00 [Reference]  —
a All values are adjusted hazard ratio (95% confidence interval). Values for propensity scores (in quintiles) are not shown, because they have no bear-
ing on the interpretation of the findings. P values are for analysis of maximum likelihood estimates; unless otherwise indicated, odds ratios are not sig-
nificant at P < .05. Analysis limited to patients diagnosed with local-stage or regional-stage cancer.
b Given the small number of events, we present the adjusted hazard ratio and 95% confidence interval from the reduced model, which included only
the BCCP variable, propensity scores, and cancer stage (the only independent variable that was significant at P < .05).
c Low educational attainment defined as residing in a census block group in which the percentage of adults with a high school diploma was in the low-
est 10th percentile, based on the distribution of this measure for women with breast cancer statewide.
d P = .02.
e P = .046.
f P < .001.
(continued on next page)
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(continued)
Table 3. Results From the Multivariable Survival Analysis, Adjusted for Propensity Scoresa, Ohio, 2000–2009
Characteristic All-Cause Survival Cancer Survivalb
1 1.23 (0.67–2.28)  —
≥2 1.82 (1.09–3.04)d  —
Cancer stage at diagnosis
Local 1.00 [Reference] 1.00 [Reference]
Regional 1.49 (1.01–2.19)e 3.59 (1.90–6.76)f
Distant  —  —
Lives in nursing home
No 1.00 [Reference]  —
Yes 2.04 (1.36–3.06)f  —
Had screening mammography in year before cancer diagnosis
No 1.00 [Reference]  —
Yes 0.68 (0.45–1.02)  —
Receipt of standard treatment
No 1.00 [Reference]  —
Yes 0.63 (0.39–1.02)  —
a All values are adjusted hazard ratio (95% confidence interval). Values for propensity scores (in quintiles) are not shown, because they have no bear-
ing on the interpretation of the findings. P values are for analysis of maximum likelihood estimates; unless otherwise indicated, odds ratios are not sig-
nificant at P < .05. Analysis limited to patients diagnosed with local-stage or regional-stage cancer.
b Given the small number of events, we present the adjusted hazard ratio and 95% confidence interval from the reduced model, which included only
the BCCP variable, propensity scores, and cancer stage (the only independent variable that was significant at P < .05).
c Low educational attainment defined as residing in a census block group in which the percentage of adults with a high school diploma was in the low-
est 10th percentile, based on the distribution of this measure for women with breast cancer statewide.
d P = .02.
e P = .046.
f P < .001.
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